Results 161 to 170 of about 83,753 (298)

Evaluating a CBCT Correction Algorithm for Adaptive Radiotherapy. [PDF]

Technol Cancer Res Treat
Sawyer C, Koo J, Naghavi A, Caudell JJ, Qayyum M, Redler G, Feygelman V, Mueller J, Johansson W, Latifi K.   +9 more
europepmc   +1 more source

LMO7 Suppresses Tumor‐Associated Macrophage Phagocytosis of Tumor Cells Through Degradation of LRP1

Advanced Science, EarlyView.
LMO7 in tumor‐associated macrophages suppresses phagocytosis of tumor cells and limits cytotoxic T lymphocytes infiltration, fostering tumor progression. Mechanistically, LMO7 mediates the ubiquitination and degradation of the phagocytic receptor LRP1, impairing its ability to engulf tumor cells and driving macrophages toward an antitumor phenotype ...
Mengkai Li, Tao Wang, Yuwen Zhong, Zhiming Wang, Wei Li, Zejian Wang, Xinyi Yang, Yu Qiao, Jianfeng Xiang, Wei Gu, Zishu Wang, Lei Sun, Feng Qian   +12 more
wiley   +1 more source

Engineering Osteoimmune Responses with Functionalized Orthopedic Implants for Post‐Operative Osteosarcoma Treatment

Advanced Science, EarlyView.
Osteosarcoma is the most common primary bone tumor with limited treatment options and a terrible prognosis. This review provides a comprehensive summary of the recent development of osteoimmunomodulatory implants for post‐operative osteosarcoma treatment, of which the potential utility in evoking durable anti‐osteosarcoma immunity and accelerating bone
Yilong Dong, Lingshuang Wang, Hui Zhang, Menghuan Li, Zhong Luo, Yan Hu, Chunyuan Cai   +6 more
wiley   +1 more source

Adaptive Radiotherapy: Moving Into the Future [PDF]

Seminars in Radiation Oncology, 2019
openaire   +2 more sources

Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy

Advanced Science, EarlyView.
Lactate, once deemed a metabolic waste, emerges as a central regulator of cancer progression. This review elucidates how lactate and its epigenetic derivative, protein lactylation, orchestrate tumor metabolism, immune suppression, and therapeutic resistance.
Jiajing Gong, Yuhang Xie, Zhijie Weng, Yongzhi Wu, Longjiang Li, Bo Li   +5 more
wiley   +1 more source

Three discipline collaborative radiation therapy (3DCRT) special debate: Equipment development is stifling innovation in radiation oncology [PDF]

, 2011
Kim, Leonard, Markovina, Stephanie, Van Nest, Samantha J, Eisaman, Subarna, Santanam, Lakshmi, Sullivan, Julie M, Dominello, Michael, Joiner, Michael C, Burmeister, Jay   +8 more
core   +3 more sources

Clinical experience with an online adaptive radiotherapy for prostate cancer: successful treatment time optimization. [PDF]

BMC Cancer
Malygina H, Salazar Zuniga B, Auerbach H, Ries M, Knobe S, Dzierma Y, Palm J, Hecht M.   +7 more
europepmc   +1 more source

Adaptive radiotherapy for nasopharyngeal carcinoma

Annals of Nasopharynx Cancer, 2020
Jishi Li, Zhiyuan Xu, Avinash Pilar, Brian O’Sullivan, Shao Hui Huang   +4 more
openaire   +1 more source

Understanding and Overcoming Antibody‐Drug Conjugate Resistance: Biological Mechanisms and Emerging Analytical Frameworks in Breast Cancer

Advanced Science, EarlyView.
Antibody–drug conjugates (ADCs) transform breast cancer therapy, yet resistance limits their durability. Emerging evidence reveals that ADC failure is not solely tumor‐intrinsic but shaped by dynamic tumor–microenvironment interactions that alter drug delivery, processing, and response.
Minji Seo, Jangsoon Lee, Naoto T. Ueno
wiley   +1 more source

Correction to: Full bladder, empty rectum? Revisiting a paradigm in the era of adaptive radiotherapy. [PDF]

Strahlenther Onkol
Malygina H, Auerbach H, Nuesken F, Palm J, Hecht M, Dzierma Y.   +5 more
europepmc   +1 more source